ClinConnect ClinConnect Logo
Search / Trial NCT04329468

Detachable String MCE for Upper Gastrointestinal Tract and Small Bowel

Launched by ZHUAN LIAO · Mar 30, 2020

Trial Information

Current as of May 12, 2025

Unknown status

Keywords

Ds Mce Z Line Duodenal Papilla Completion Rate

ClinConnect Summary

Magnetically controlled capsule endoscopy (MCE) has been widely used in clinical practice for upper gastrointestinal (UGI) tract and Small Bowel. However, the complete visualization of UGI tract still present challenges due to rapid transit through esophagus and duodenum, although technical improvements of MCE are helpful.

Detachable String MCE (DS-MCE) can control the movement of MCE through the string and MCE can start next examination after string detachment, which was proved to be an effective and safe method for complete viewing of the esophagus and stomach. In order to improve the du...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Adult patients aged 18 to 80
  • 2. With or without gastrointestinal complaints
  • 3. Scheduled to undergo a capsule endoscopy for both stomach and small bowel
  • 4. Signed the informed consents before joining this study
  • Exclusion Criteria:
  • 1. Pacemakers or electromedical devices implanted which are incompatible with magnetic field;
  • 2. Suspected or known gastrointestinal stenosis, obstruction or other known risk factors for capsule retention;
  • 3. Scheduled magnetic resonance imaging examination before excretion of capsule;
  • 4. Pregnancy or suspected pregnancy;
  • 5. Any contraindications about EGD.
  • 6. Other circumstances that doctors consider inappropriate for the study.

About Zhuan Liao

Zhuan Liao is a prominent clinical trial sponsor dedicated to advancing medical research and innovation. With a focus on delivering high-quality clinical trials across various therapeutic areas, Zhuan Liao collaborates with healthcare professionals and institutions to ensure rigorous study design and execution. The organization prioritizes patient safety and ethical standards while striving to accelerate the development of effective treatments. Committed to transparency and scientific integrity, Zhuan Liao plays a vital role in bridging the gap between groundbreaking research and real-world applications in healthcare.

Locations

Shanghai, , China

Patients applied

0 patients applied

Trial Officials

Zhuan Liao

Study Director

Changhai Hospital, Shanghai, China

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials